Adjuvanted meningococcus compositions
    5.
    再颁专利
    Adjuvanted meningococcus compositions 有权
    佐剂脑膜炎球菌组成

    公开(公告)号:USRE45137E1

    公开(公告)日:2014-09-16

    申请号:US13587840

    申请日:2012-08-16

    摘要: A combination of CpG oligonucleotides and polymer microparticles is an extremely effective adjuvant for Neisserial antigens. The invention therefore provides a composition comprising: (a) a Neisserial antigen; (b) a CpG oligonucleotide; and (c) a biodegradable polymer microparticle.

    摘要翻译: CpG寡核苷酸和聚合物微粒的组合是奈瑟氏球菌抗原非常有效的佐剂。 因此,本发明提供一种组合物,其包含:(a)奈维菌素抗原; (b)CpG寡核苷酸; 和(c)可生物降解的聚合物微粒。

    Immunogenic compositions containing phospholipid
    6.
    发明授权
    Immunogenic compositions containing phospholipid 有权
    含有磷脂的免疫原性组合物

    公开(公告)号:US08541023B2

    公开(公告)日:2013-09-24

    申请号:US13270107

    申请日:2011-10-10

    申请人: Derek O'Hagan

    发明人: Derek O'Hagan

    摘要: Immunogenic compositions containing phospholipid adjuvants, including microparticle and emulsion compositions. According to one aspect of the invention, an immunogenic microparticle composition is provided comprising: water; a polymer microparticle; an antigen adsorbed to the microparticle; and a phospholipid compound, e.g., a synthetic phospholipid compound comprising: (i) one or more phosphoryl groups independently selected from a phosphato group and a phosphodiester group; (ii) a plurality of linear alkane groups. According to another aspect of the invention an immunogenic emulsion composition is provided that comprises: water; a metabolizable oil; an emulsifying agent; an antigen; and a phospholipid compound, e.g., a synthetic phospholipid compound like that above. The emulsion composition is an oil-in-water emulsion having oil and aqueous phases, in which the oil phase is in the form of oil droplets, substantially all of which are less than 1 micron in diameter.

    摘要翻译: 含有磷脂佐剂的免疫原性组合物,包括微粒和乳剂组合物。 根据本发明的一个方面,提供免疫原性微粒组合物,其包含:水; 聚合物微粒; 吸附在微粒上的抗原; 和磷脂化合物,例如合成磷脂化合物,其包含:(i)一个或多个独立地选自磷酸酯基和磷酸二酯基团的磷酰基; (ii)多个直链烷烃基团。 根据本发明的另一方面,提供免疫原性乳剂组合物,其包含:水; 代谢油; 乳化剂; 抗原; 和磷脂化合物,例如如上所述的合成磷脂化合物。 乳液组合物是具有油相和水相的水包油乳液,其中油相是油滴形式,其基本上都小于1微米直径。

    MUCOSAL MENINGOCOCCAL VACCINES
    10.
    发明申请
    MUCOSAL MENINGOCOCCAL VACCINES 审中-公开
    粘膜肉芽孢杆菌疫苗

    公开(公告)号:US20110150923A1

    公开(公告)日:2011-06-23

    申请号:US13036007

    申请日:2011-02-28

    摘要: The invention provides immunogenic compositions for mucosal delivery comprising capsular saccharides from at least two of serogroups A, C, W135 and Y of N. meningitidis. It is preferred that the capsular saccharides in the compositions of the invention are conjugated to carrier protein(s) and/or are oligosaccharides. Conjugated oligosaccharide antigens are particularly preferred. The invention also provides immunogenic compositions comprising (a) a capsular saccharide antigen from serogroup C of N. meningitidis, and (b) a chitosan adjuvant. The composition preferably comprises (c) one or more further antigens and/or (d) one or more further adjuvants. The compositions are particularly suitable for mucosal delivery, including intranasal delivery. The use of chitosan and/or detoxified ADP-ribosylating toxin adjuvants enhances anti-meningococcal mucosal immune responses and can shift the Th1/Th2 bias of the responses.

    摘要翻译: 本发明提供用于粘膜递送的免疫原性组合物,其包含来自脑膜炎奈瑟菌脑膜炎的血清群A,C,W135和Y的至少两个的荚膜糖。 本发明组合物中的荚膜糖优选与载体蛋白结合,和/或是寡糖。 共轭寡糖抗原是特别优选的。 本发明还提供免疫原性组合物,其包含(a)来自脑膜炎奈瑟氏球菌的血清群C的荚膜糖抗原和(b)壳聚糖佐剂。 组合物优选包含(c)一种或多种另外的抗原和/或(d)一种或多种另外的佐剂。 组合物特别适用于粘膜递送,包括鼻内递送。 使用壳聚糖和/或解毒的ADP-核糖基化毒素佐剂增强了抗脑膜炎球菌粘膜免疫应答,并且可以改变反应的Th1 / Th2偏差。